Oleksandr Boichuk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Oleksandr Boichuk has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Oleksandra Pryshliak
Івано-Франківський національний медичний університет
6 shared publications - Andrii Protsyk
Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine
4 shared publications - Zoriana Tylishchak
Department of Infectious Diseases and Epidemiology, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine
4 shared publications - Руслан Мізюк
Івано-Франківський національний медичний університет
3 shared publications - Тарас Кобрин
Department of Infectious Diseases and Epidemiology, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine
3 shared publications - Nadiya Vaskul
Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine
2 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Ternopil State Medical University in Інфекційні хвороби
- No. 3,p. 45-50
Лайм-артрит: сучасні підходи до діагностики та лікування в Україні
Lyme borreliosis is a common naturally occurring, vector-borne disease, and Lyme arthritis is one of its characteristic late articular manifestations. Diagnosis of this form may be challenging because of the wide interval between infection and the onset of arthritis, the need to differentiate it from other causes of monoarthritis or oligoarthritis, and the prolonged persistence of specific antibodies after resolution of the infection. Objective. To summarize current evidence on the clinical manifestations, timing of onset, diagnosis, and treatment of Lyme arthritis and to determine the specific features of applying current approaches in Ukraine. Current scientific publications, international clinical guidelines, and Ukrainian regulatory, clinical, and epidemiological materials were analyzed. Lyme arthritis most commonly presents as asymmetric monoarthritis or oligoarthritis of large joints, predominantly the knees, with pronounced synovitis and joint effusion. Unlike early arthralgia, true arthritis usually develops several months after infection, although the interval may vary considerably. The cornerstone of laboratory diagnosis is serological testing for specific IgG antibodies. Positive serology alone does not prove active infection, as antibodies may persist for a prolonged period. PCR testing of synovial fluid may provide additional diagnostic information in seropositive patients when greater diagnostic certainty is required, but it is not recommended as a primary screening method. Treatment consists of a 28-day course of oral antibiotics; intravenous ceftriaxone may be considered in patients with an inadequate response. Persistence of synovitis after adequate antibacterial therapy does not necessarily indicate ongoing active infection and may represent post-antibiotic Lyme arthritis. Conclusions. The diagnosis of Lyme arthritis should be based on a combination of the characteristic clinical phenotype, epidemiological context, and appropriate interpretation of serological test results. In Ukraine, an important priority remains the accumulation of standardized clinical data and the implementation of unified approaches to the diagnosis and treatment of Lyme arthritis.
- 30 September 2026
- Published by Ternopil State Medical University in Інфекційні хвороби
- No. 3,p. 45-50
Open AccessЛайм-артрит: сучасні підходи до діагностики та лікування в Україні
Lyme borreliosis is a common naturally occurring, vector-borne disease, and Lyme arthritis is one of its characteristic late articular manifestations. Diagnosis of this form may be challenging because of the wide interval between infection and the onset of arthritis, the need to differentiate it from other causes of monoarthritis or oligoarthritis, and the prolonged persistence of specific antibodies after resolution of the infection. Objective. To summarize current evidence on the clinical manifestations, timing of onset, diagnosis, and treatment of Lyme arthritis and to determine the specific features of applying current approaches in Ukraine. Current scientific publications, international clinical guidelines, and Ukrainian regulatory, clinical, and epidemiological materials were analyzed. Lyme arthritis most commonly presents as asymmetric monoarthritis or oligoarthritis of large joints, predominantly the knees, with pronounced synovitis and joint effusion. Unlike early arthralgia, true arthritis usually develops several months after infection, although the interval may vary considerably. The cornerstone of laboratory diagnosis is serological testing for specific IgG antibodies. Positive serology alone does not prove active infection, as antibodies may persist for a prolonged period. PCR testing of synovial fluid may provide additional diagnostic information in seropositive patients when greater diagnostic certainty is required, but it is not recommended as a primary screening method. Treatment consists of a 28-day course of oral antibiotics; intravenous ceftriaxone may be considered in patients with an inadequate response. Persistence of synovitis after adequate antibacterial therapy does not necessarily indicate ongoing active infection and may represent post-antibiotic Lyme arthritis. Conclusions. The diagnosis of Lyme arthritis should be based on a combination of the characteristic clinical phenotype, epidemiological context, and appropriate interpretation of serological test results. In Ukraine, an important priority remains the accumulation of standardized clinical data and the implementation of unified approaches to the diagnosis and treatment of Lyme arthritis.
- 25 August 2026
- Published by Springer Nature in Rheumatology International
- Vol. 46 (9) , 246
Ankylosing spondylitis following chronic brucellosis: a causal association or separate pathology? A case-based review
Brucellosis is a widespread zoonotic infection that often follows a chronic course and may involve the osteoarticular system. Patients with brucellosis-related musculoskeletal manifestations are frequently evaluated by rheumatologists and may be misdiagnosed with rheumatic diseases, including ankylosing spondylitis. We present the case of a 45-year-old female patient who was diagnosed with osteoarticular brucellosis approximately 20 years ago and was successfully treated with etiotropic therapy. Eighteen years later, she developed back pain that worsened at night and did not improve with rest, accompanied by morning stiffness. Further evaluation revealed negative specific anti-Brucella antibodies, HLA-B27 positivity confirmed by polymerase chain reaction, and magnetic resonance imaging findings supporting the diagnosis of ankylosing spondylitis/axial spondyloarthritis. A literature review including 21 relevant sources was conducted to analyse the diagnostic overlap and possible coexistence of brucellosis and ankylosing spondylitis. The reviewed evidence, together with the clinical course of the present patient, supports the interpretation that ankylosing spondylitis developed as a separate pathological condition rather than as a direct consequence of previously treated brucellosis. This case highlights the importance of careful differential diagnosis between brucellosis-related osteoarticular involvement and axial spondyloarthritis, particularly in patients from brucellosis-endemic regions or with relevant epidemiological exposure.
- 25 August 2026
- Published by Springer Nature in Rheumatology International
- Vol. 46 (9) , 246
Ankylosing spondylitis following chronic brucellosis: a causal association or separate pathology? A case-based review
Brucellosis is a widespread zoonotic infection that often follows a chronic course and may involve the osteoarticular system. Patients with brucellosis-related musculoskeletal manifestations are frequently evaluated by rheumatologists and may be misdiagnosed with rheumatic diseases, including ankylosing spondylitis. We present the case of a 45-year-old female patient who was diagnosed with osteoarticular brucellosis approximately 20 years ago and was successfully treated with etiotropic therapy. Eighteen years later, she developed back pain that worsened at night and did not improve with rest, accompanied by morning stiffness. Further evaluation revealed negative specific anti-Brucella antibodies, HLA-B27 positivity confirmed by polymerase chain reaction, and magnetic resonance imaging findings supporting the diagnosis of ankylosing spondylitis/axial spondyloarthritis. A literature review including 21 relevant sources was conducted to analyse the diagnostic overlap and possible coexistence of brucellosis and ankylosing spondylitis. The reviewed evidence, together with the clinical course of the present patient, supports the interpretation that ankylosing spondylitis developed as a separate pathological condition rather than as a direct consequence of previously treated brucellosis. This case highlights the importance of careful differential diagnosis between brucellosis-related osteoarticular involvement and axial spondyloarthritis, particularly in patients from brucellosis-endemic regions or with relevant epidemiological exposure.
- Open Access
- 30 June 2025
- Published by Ivano-Frankivsk National Medical University in Прикарпатський вісник наукового товариства імені Шевченка. ПУЛЬС
- No. 23 (78),p. 89-99
ПОРІВНЯЛЬНА ЕФЕКТИВНІСТЬ ЗАСТОСУВАННЯ ТОЦИЛІЗУМАБУ ТА ВИСОКИХ ДОЗ ГЛЮКОКОРТИКОЇДІВ У ХВОРИХ НА COVID-19
При тяжкому і критичному перебігу COVID-19 для усунення ефектів «цитокінового шторму» призначають глюкокортикостероїди або тоцілізумаб. Мета. Порівняти ефективність тоцилізумабу та підвищених доз глюкокортикоїдів у хворих на коронавірусну хворобу COVID-19 з тяжким перебігом та дихальною недостатністю в умовах відділення інтенсивної терапії. Матеріал і методи. Проведено ретроспективний аналіз 20 випадків захворювання на COVID-19 із тяжким і критичним перебігом. Середній вік пацієнтів 70,6±3,7 року. І група включала 10 осіб, які отримували тоцилізумаб з курсовою дозою 800 мг; ІІ група - 10 осіб, які отримували глюкокортикоїди у курсовій дозі 580-1530 мг за 5 днів. В динаміці визначали показники загального аналізу крові, коагулограму, СРБ, прокальцитонін. Статистична обробка результатів проводилася непараметричними методами з використанням U-критерію Манна-Уітні, Хі-квадрат тесту і критерію знаків G. Результати. В І групі до лікування кількість лейкоцитів в межах 8,9-15,5 ×109/л, лімфоцити в межах 0,69-2,1×109/л, еозинопенія 0-1%, нейтрофільно-лімфоцитарний індекс – 4,9-10,9; ШОЕ – 24-53 мм/год, СРБ –36-108 мг/л, прокальцитонін – 0,1-2,5 нг/мл. Після застосування тоцилізумабу виявлено факт гіперлейкоцитозу (26,4 ×109 /л - 39,4 × 109 /л) у 6 хворих (60,0 %). Прокальцитонін також підвищувався до меж 0,6 - 7,9 нг/мл. У ІІ групі лабораторні показники до лікування мали аналогічні значення. Після застосування ГКС спостерігався помірний лейкоцитоз (9,2 ×109 /л – 25,5 ×109 /л) та підвищення прокальцитоніну 0,13 - 4,7 нг/мл. У І групі летальних випадків було 7 (70,0 %), а у ІІ групі - 5 (50,0%), p>0,05. Висновки. Застосування 800 мг тоцилізумабу супроводилося гіперлейкоцитозом у частини хворих, та ознаками генералізованої септичної інфекції на відміну від застосування високих ГКС.
- 30 June 2025
- Published by Ivano-Frankivsk National Medical University in Прикарпатський вісник наукового товариства імені Шевченка. ПУЛЬС
- No. 23 (78),p. 89-99
Open AccessПОРІВНЯЛЬНА ЕФЕКТИВНІСТЬ ЗАСТОСУВАННЯ ТОЦИЛІЗУМАБУ ТА ВИСОКИХ ДОЗ ГЛЮКОКОРТИКОЇДІВ У ХВОРИХ НА COVID-19
При тяжкому і критичному перебігу COVID-19 для усунення ефектів «цитокінового шторму» призначають глюкокортикостероїди або тоцілізумаб. Мета. Порівняти ефективність тоцилізумабу та підвищених доз глюкокортикоїдів у хворих на коронавірусну хворобу COVID-19 з тяжким перебігом та дихальною недостатністю в умовах відділення інтенсивної терапії. Матеріал і методи. Проведено ретроспективний аналіз 20 випадків захворювання на COVID-19 із тяжким і критичним перебігом. Середній вік пацієнтів 70,6±3,7 року. І група включала 10 осіб, які отримували тоцилізумаб з курсовою дозою 800 мг; ІІ група - 10 осіб, які отримували глюкокортикоїди у курсовій дозі 580-1530 мг за 5 днів. В динаміці визначали показники загального аналізу крові, коагулограму, СРБ, прокальцитонін. Статистична обробка результатів проводилася непараметричними методами з використанням U-критерію Манна-Уітні, Хі-квадрат тесту і критерію знаків G. Результати. В І групі до лікування кількість лейкоцитів в межах 8,9-15,5 ×109/л, лімфоцити в межах 0,69-2,1×109/л, еозинопенія 0-1%, нейтрофільно-лімфоцитарний індекс – 4,9-10,9; ШОЕ – 24-53 мм/год, СРБ –36-108 мг/л, прокальцитонін – 0,1-2,5 нг/мл. Після застосування тоцилізумабу виявлено факт гіперлейкоцитозу (26,4 ×109 /л - 39,4 × 109 /л) у 6 хворих (60,0 %). Прокальцитонін також підвищувався до меж 0,6 - 7,9 нг/мл. У ІІ групі лабораторні показники до лікування мали аналогічні значення. Після застосування ГКС спостерігався помірний лейкоцитоз (9,2 ×109 /л – 25,5 ×109 /л) та підвищення прокальцитоніну 0,13 - 4,7 нг/мл. У І групі летальних випадків було 7 (70,0 %), а у ІІ групі - 5 (50,0%), p>0,05. Висновки. Застосування 800 мг тоцилізумабу супроводилося гіперлейкоцитозом у частини хворих, та ознаками генералізованої септичної інфекції на відміну від застосування високих ГКС.
- 6 December 2024
- Published by ALUNA in Wiadomości Lekarskie
- Vol. 77 (10) , 1962-1968
Effectiveness of the quercetin use in patients with COVID-19 with concomitant type 2 diabetes mellitus
Aim: To conduct a comparative analysis of the effectiveness of basic therapy and basic therapy with the inclusion of quercetin in patients with COVID-19 with concomitant type 2 diabetes.Material and methods: There were examined 60 patients with COVID-19 with concomitant T2DM. Upon admission into the hospital and again after 10 days, serum levels of interleukin-6, C-reactive protein, procalcitonin, ferritin, endothelin-1 were determined, and capillaroscopy of the nail plate was performed. Patients of the group I (30) against the background of protocol therapy received 0.5 g of quercetin intravenously once a day for 10 days. Patients of the group II (30) received to basic therapy.Results: After the treatment in patients of the group I general weakness decreased, body temperature normalized, improved saturation indicators, the level of acute-phase parameters (interleukin-6, CRP and ferritin) significantly decreased, a positive effect of quercetin on the level of D-dimer in blood serum was noted, indices of pericapillary edema and hemosiderin deposition significantly decreased, indices diameter of the arterial part of the capillary and capillary network density significantly increased.Conclusions: The use of quercetin against the background of basic therapy in patients with COVID-19 and concomitant T2DM reliably reduces the level of acute-phase indices, has an important clinical significance for reducing endothelial dysfunction and for preventing thrombotic complications.
- 6 December 2024
- Published by ALUNA in Wiadomości Lekarskie
- Vol. 77 (10) , 1962-1968
Effectiveness of the quercetin use in patients with COVID-19 with concomitant type 2 diabetes mellitus
Aim: To conduct a comparative analysis of the effectiveness of basic therapy and basic therapy with the inclusion of quercetin in patients with COVID-19 with concomitant type 2 diabetes.Material and methods: There were examined 60 patients with COVID-19 with concomitant T2DM. Upon admission into the hospital and again after 10 days, serum levels of interleukin-6, C-reactive protein, procalcitonin, ferritin, endothelin-1 were determined, and capillaroscopy of the nail plate was performed. Patients of the group I (30) against the background of protocol therapy received 0.5 g of quercetin intravenously once a day for 10 days. Patients of the group II (30) received to basic therapy.Results: After the treatment in patients of the group I general weakness decreased, body temperature normalized, improved saturation indicators, the level of acute-phase parameters (interleukin-6, CRP and ferritin) significantly decreased, a positive effect of quercetin on the level of D-dimer in blood serum was noted, indices of pericapillary edema and hemosiderin deposition significantly decreased, indices diameter of the arterial part of the capillary and capillary network density significantly increased.Conclusions: The use of quercetin against the background of basic therapy in patients with COVID-19 and concomitant T2DM reliably reduces the level of acute-phase indices, has an important clinical significance for reducing endothelial dysfunction and for preventing thrombotic complications.
- 3 November 2024
- Published by ALUNA in Wiadomości Lekarskie
- Vol. 77 (9) , 1718-1725
Lyme borreliosis in Ivano-Frankivsk district, Ukraine: a epidemiological and clinical characteristics (2000-2022)
Aim: To give epidemiological and clinical characteristics of the morbidity of Lyme borreliosis in Ivano-Frankivsk region for the period of 2000-2022 years.Material and methods: There were used annual reports (form №1) from the State Institution “Ivano-Frankivsk Regional Center for Disease Control and Prevention of the Ministry of Health of Ukraine” and 200 of “Medical records of inpatients” (form 003/о) of the Ivano-Frankivsk Regional Clinical Infectious Diseases Hospital for 2000-2022 years.Results: The morbidity of Lyme borreliosis in the Ivano-Frankivsk region has been permanently increasing since 2000. Natural foci have been identified, the number of which is increasing every year. There was noted late admission of patients to the Infectious Disease Hospital from the beginning of the disease, mainly at the stage of migratory annular erythema. There were almost no phenomena of intoxication and fever during the acute period. There were often observed the phenomena of hepatosis, joint damage and manifestations of the nervous system at the disseminated and chronic stages.Conclusions: All landscape zones of Ivano-Frankivsk region are enzootic regarding Lyme borreliosis. Over the last 10 years in the region there is a tendency to a sharp increase of Lyme borreliosis morbidity. The clinical peculiarities of the disease in Ivano-Frankivsk region are: the absence of intoxication at the stage of migratory erythema, the phenomena of hepatosis. During the second and third stages of the disease there are polymorphic symptoms: recurrent erythema, damage of the retina, joints, liver, nervous system.
- 3 November 2024
- Published by ALUNA in Wiadomości Lekarskie
- Vol. 77 (9) , 1718-1725
Lyme borreliosis in Ivano-Frankivsk district, Ukraine: a epidemiological and clinical characteristics (2000-2022)
Aim: To give epidemiological and clinical characteristics of the morbidity of Lyme borreliosis in Ivano-Frankivsk region for the period of 2000-2022 years.Material and methods: There were used annual reports (form №1) from the State Institution “Ivano-Frankivsk Regional Center for Disease Control and Prevention of the Ministry of Health of Ukraine” and 200 of “Medical records of inpatients” (form 003/о) of the Ivano-Frankivsk Regional Clinical Infectious Diseases Hospital for 2000-2022 years.Results: The morbidity of Lyme borreliosis in the Ivano-Frankivsk region has been permanently increasing since 2000. Natural foci have been identified, the number of which is increasing every year. There was noted late admission of patients to the Infectious Disease Hospital from the beginning of the disease, mainly at the stage of migratory annular erythema. There were almost no phenomena of intoxication and fever during the acute period. There were often observed the phenomena of hepatosis, joint damage and manifestations of the nervous system at the disseminated and chronic stages.Conclusions: All landscape zones of Ivano-Frankivsk region are enzootic regarding Lyme borreliosis. Over the last 10 years in the region there is a tendency to a sharp increase of Lyme borreliosis morbidity. The clinical peculiarities of the disease in Ivano-Frankivsk region are: the absence of intoxication at the stage of migratory erythema, the phenomena of hepatosis. During the second and third stages of the disease there are polymorphic symptoms: recurrent erythema, damage of the retina, joints, liver, nervous system.
- Open Access
- 20 July 2022
- Published by Ivano-Frankivsk National Medical University in Art of Medicine
- Vol. 22 (2) , 86-91
THE ROLE OF PROBIOTICS IN THE TREATMENT OF INTESTINAL DYSBIOSIS IN PATIENTS WITH LAMBLIOSIS AND ASCARIDOSIS
Parasitic diseases remain an important problem today. Recently, many cases of combined invasion have been registered. Mixed invasion by Giardia and roundworms is the most common in Ukraine. The clinical picture of the disease is characterized by damage to various organs and systems, but most often in patients the manifestations relate to the primary site of parasitism of pathogens - the gastrointestinal tract, which is often accompanied by disruption of the intestinal microflora. The aim was to study the effect of probiotics containing bicarbonate saccharomycetes in the complex therapy of patients with giardiasis, ascariasis, and combined invasion. We examined 90 patients with giardiasis, ascariasis, and combined invasion, divided into 3 groups, depending on the type of invasion, each of which is divided into two subgroups, depending on the treatment (basic treatment and with the addition of probiotics). It was administered orally 1 capsule 2 times a day for 14 days. 1 capsule contains 250 mg of saccharomycetes and excipients. The control group consisted of 20 healthy individuals. The state of the intestinal microflora was determined using a classical microbiological study of feces to determine the population level of the microflora according to VA Znamensky. The research was performed twice: before treatment and 14 days after treatment. The diagnosis of giardiasis and ascariasis was confirmed by detection of the pathogen in the feces by parasitoscopy of feces. When studying the state of the intestinal microflora, it was found that all patients had the following changes before treatment. The content of bifidobacteria, lactobacilli, enterococci and the total content of E. coli was reduced. At the same time, there was an increase in the content of peptococci, bacteroids, Escherichia coli with weakly enzymatic properties, haemolytic Escherichia coli, fungi of the genus Candida and staphylococci. After the basic treatment, some positive changes were observed in all groups of patients, but the content of autochthonous flora still decreased, the presence of pathogenic bacteria (staphylococci) and fungal flora was noted. The content of bifidobacteria was slightly reduced. The quantitative composition of lactobacilli was higher than before treatment. Patients had a reduced amount of bacteroids, total Escherichia coli, although its content was higher than before treatment. An elevated level of Escherichia coli with weak enzymatic properties was noted. Hemolytic Escherichia coli was present, as well as the number of enterococci. Fungi of the genus Candida were available also. In the 3b group of patients there were more significant signs of improvement in the microflora. After the inclusion in the treatment complex of probiotics containing saccharomycetes of billard, according to the results of bacteriological research, there was a significant positive dynamic of the intestinal microflora. The content of bifidobacteria was significantly higher compared to the other two groups. The quantitative composition of lactobacilli was slightly reduced. The amount of bacteroids was normalized. The total content of Escherichia coli increased, there was a decrease in the content of Escherichia coli with weak enzymatic properties. In addition, the presence of haemolytic Escherichia coli was detected in only one patient. Almost complete normalization of the level of enterococci was observed. From the fungal flora, the level of fungi of the genus Candida was minimal, comparing similar results of other groups.
- 20 July 2022
- Published by Ivano-Frankivsk National Medical University in Art of Medicine
- Vol. 22 (2) , 86-91
Open AccessTHE ROLE OF PROBIOTICS IN THE TREATMENT OF INTESTINAL DYSBIOSIS IN PATIENTS WITH LAMBLIOSIS AND ASCARIDOSIS
Parasitic diseases remain an important problem today. Recently, many cases of combined invasion have been registered. Mixed invasion by Giardia and roundworms is the most common in Ukraine. The clinical picture of the disease is characterized by damage to various organs and systems, but most often in patients the manifestations relate to the primary site of parasitism of pathogens - the gastrointestinal tract, which is often accompanied by disruption of the intestinal microflora. The aim was to study the effect of probiotics containing bicarbonate saccharomycetes in the complex therapy of patients with giardiasis, ascariasis, and combined invasion. We examined 90 patients with giardiasis, ascariasis, and combined invasion, divided into 3 groups, depending on the type of invasion, each of which is divided into two subgroups, depending on the treatment (basic treatment and with the addition of probiotics). It was administered orally 1 capsule 2 times a day for 14 days. 1 capsule contains 250 mg of saccharomycetes and excipients. The control group consisted of 20 healthy individuals. The state of the intestinal microflora was determined using a classical microbiological study of feces to determine the population level of the microflora according to VA Znamensky. The research was performed twice: before treatment and 14 days after treatment. The diagnosis of giardiasis and ascariasis was confirmed by detection of the pathogen in the feces by parasitoscopy of feces. When studying the state of the intestinal microflora, it was found that all patients had the following changes before treatment. The content of bifidobacteria, lactobacilli, enterococci and the total content of E. coli was reduced. At the same time, there was an increase in the content of peptococci, bacteroids, Escherichia coli with weakly enzymatic properties, haemolytic Escherichia coli, fungi of the genus Candida and staphylococci. After the basic treatment, some positive changes were observed in all groups of patients, but the content of autochthonous flora still decreased, the presence of pathogenic bacteria (staphylococci) and fungal flora was noted. The content of bifidobacteria was slightly reduced. The quantitative composition of lactobacilli was higher than before treatment. Patients had a reduced amount of bacteroids, total Escherichia coli, although its content was higher than before treatment. An elevated level of Escherichia coli with weak enzymatic properties was noted. Hemolytic Escherichia coli was present, as well as the number of enterococci. Fungi of the genus Candida were available also. In the 3b group of patients there were more significant signs of improvement in the microflora. After the inclusion in the treatment complex of probiotics containing saccharomycetes of billard, according to the results of bacteriological research, there was a significant positive dynamic of the intestinal microflora. The content of bifidobacteria was significantly higher compared to the other two groups. The quantitative composition of lactobacilli was slightly reduced. The amount of bacteroids was normalized. The total content of Escherichia coli increased, there was a decrease in the content of Escherichia coli with weak enzymatic properties. In addition, the presence of haemolytic Escherichia coli was detected in only one patient. Almost complete normalization of the level of enterococci was observed. From the fungal flora, the level of fungi of the genus Candida was minimal, comparing similar results of other groups.
- Open Access
- 1 August 2020
- Published by ALUNA in Wiadomości Lekarskie
- Vol. 73 (8) , 1671-1676
FUNCTIONAL STATE OF NEUTROPHIC GRANULOCYTES’ GENOME OF THE PERIPHERAL BLOOD IN PATIENTS WITH CHRONIC HEPATITIS C WITH CONCOMITANT DIABETES MELLITUS TYPE II
The aim: To determine changes of FSG of neutrophilic granulocytes of peripheral blood (NGPB) of patients with CHC with concomitant DM-2. Materials and methods: We've examined 180 patients with CHC: 160 with concomitant diabetes mellitus and 20 ones without it. The NGPB genome was studied using cytogenetic method. There were analyzed 100 interphase NGPB nuclei in the preparation, structural characteristics were evaluated according to indices: chromatization (IC), nucleolar (IN), pathologically altered nuclei (PAN), micronuclei (MNI). Results: Violations of FSG OF NGPBwere found according to all indices in patients with CHC, they were more pronounced in patients with concomitant DM-2. Conclusions: FSG NGPB is more disordered in CHC with concomitant DM-2. The reduction of IC in CHC with concomitant DM-2 is more pronounced in men. Reduction of IN in patients with CHC with and without DM-2 is a marker of violations of the second stage of realization of hereditary information. The tendency to change the components of the cytogenetic status of all examined patients due to the frequency of MNI was determined.
- 1 August 2020
- Published by ALUNA in Wiadomości Lekarskie
- Vol. 73 (8) , 1671-1676
Open AccessFUNCTIONAL STATE OF NEUTROPHIC GRANULOCYTES’ GENOME OF THE PERIPHERAL BLOOD IN PATIENTS WITH CHRONIC HEPATITIS C WITH CONCOMITANT DIABETES MELLITUS TYPE II
The aim: To determine changes of FSG of neutrophilic granulocytes of peripheral blood (NGPB) of patients with CHC with concomitant DM-2. Materials and methods: We've examined 180 patients with CHC: 160 with concomitant diabetes mellitus and 20 ones without it. The NGPB genome was studied using cytogenetic method. There were analyzed 100 interphase NGPB nuclei in the preparation, structural characteristics were evaluated according to indices: chromatization (IC), nucleolar (IN), pathologically altered nuclei (PAN), micronuclei (MNI). Results: Violations of FSG OF NGPBwere found according to all indices in patients with CHC, they were more pronounced in patients with concomitant DM-2. Conclusions: FSG NGPB is more disordered in CHC with concomitant DM-2. The reduction of IC in CHC with concomitant DM-2 is more pronounced in men. Reduction of IN in patients with CHC with and without DM-2 is a marker of violations of the second stage of realization of hereditary information. The tendency to change the components of the cytogenetic status of all examined patients due to the frequency of MNI was determined.
- Open Access
- 1 November 2016
- Published by Ivano-Frankivsk National Medical University in Galician Medical Journal
- Vol. 23 (4) , E2016415
Improvement of the Effectiveness of Antiviral Treatment of Patients with Chronic Hepatitis C and Concomitant Diabetes Mellitus Type II using Alpha-Lipoic Acid and Lactulose
Imbalance of pro-inflammatory and anti-inflammatory cytokines was detected in 104 examined the patients with chronic hepatitis C. These changes were the most significant in patients with concomitant diabetes mellitus (DM) type II. Achievement of sustained viral response (SVR) under the influence of antiviral therapy depends on the state of cytokines system. This was evidenced by the detected correlation relationship between the levels of viral load (VL) in patients with concomitant diabetes mellitus type II, namely, direct weak one between IL-4 and VL (r=0.21) and reverse weak one between the level of IL-2 and VL (r=-0.04). Virus elimination rate and frequency influenced by anti-viral therapy (AVT) depends on the balance of pro-inflammatory and anti-inflammatory cytokines. This was shown in the research by detection of direct medium correlation relationship between VL and IL-4 (r= 0.31) and reverse medium correlation relationship between VL and IL-2 (r= -0.45).
- 1 November 2016
- Published by Ivano-Frankivsk National Medical University in Galician Medical Journal
- Vol. 23 (4) , E2016415
Open AccessImprovement of the Effectiveness of Antiviral Treatment of Patients with Chronic Hepatitis C and Concomitant Diabetes Mellitus Type II using Alpha-Lipoic Acid and Lactulose
Imbalance of pro-inflammatory and anti-inflammatory cytokines was detected in 104 examined the patients with chronic hepatitis C. These changes were the most significant in patients with concomitant diabetes mellitus (DM) type II. Achievement of sustained viral response (SVR) under the influence of antiviral therapy depends on the state of cytokines system. This was evidenced by the detected correlation relationship between the levels of viral load (VL) in patients with concomitant diabetes mellitus type II, namely, direct weak one between IL-4 and VL (r=0.21) and reverse weak one between the level of IL-2 and VL (r=-0.04). Virus elimination rate and frequency influenced by anti-viral therapy (AVT) depends on the balance of pro-inflammatory and anti-inflammatory cytokines. This was shown in the research by detection of direct medium correlation relationship between VL and IL-4 (r= 0.31) and reverse medium correlation relationship between VL and IL-2 (r= -0.45).